![Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study](https://www.frontiersin.org/files/Articles/990224/fimmu-13-990224-HTML/image_m/fimmu-13-990224-t002.jpg)
Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
Auditory and sexual preferences for a father's song can co-emerge in female Bengalese finches | PLOS ONE
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial | PLOS ONE
![IKCS 2022: Real-world Clinical Outcomes of Patients with Metastatic Renal Cell Carcinoma Receiving Pembrolizumab + Axitinib vs Ipilimumab + Nivolumab IKCS 2022: Real-world Clinical Outcomes of Patients with Metastatic Renal Cell Carcinoma Receiving Pembrolizumab + Axitinib vs Ipilimumab + Nivolumab](https://www.urotoday.com/images/com-doc-importer/91-ikcs-2022/ikcs-2022-real-world-clinical-outcomes-of-patients-with-metastatic-renal-cell-carcinoma-receiving-pembrolizumab-axitinib-vs-ipilimumab-nivolumab/image-0.jpg)